Influence of the pyruvate kinase activator mitapivat (AG-348) on RBC ATP content and export and RBC adhesivity in blood from healthy subjects and sickle cell disease patients - Top-Institutions - MDSpire

Influence of the pyruvate kinase activator mitapivat (AG-348) on RBC ATP content and export and RBC adhesivity in blood from healthy subjects and sickle cell disease patients

  • By

  • Apoorva Jagadish

  • Youwei Chen

  • Hongmei Zhu

  • Weijia Mai

  • Shein-Chung Chow

  • Zhong Li

  • Grace M. Lee

  • Marilyn J. Telen

  • Tim J. McMahon

  • June 29, 2026

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    National Heart, Lung, and Blood Institute (NHLBI)
    National Heart, Lung, and Blood Institute (NHLBI)

    Bethesda, Maryland

    Key Differentiators

    • Sickle Cell Disease
    • Hematology

  • #2

    Duke University Medical Center
    Duke University Medical Center

    Durham, North Carolina

    Key Differentiators

    • Hematology
    • Erythrocyte Biology

  • #3

    University Medical Center of Goettingen
    University Medical Center of Goettingen

    Goettingen, Germany

    Key Differentiators

    • Hematology

  • #4

    Institute of Biomedical Sciences of the University of São Paulo
    Institute of Biomedical Sciences of the University of São Paulo

    São Paulo, Brazil

    Key Differentiators

    • Hematology
    • Biomedical Sciences

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Influence of the pyruvate kinase activator mitapivat (AG-348) on RBC ATP content and export and RBC adhesivity in blood from healthy subjects and sickle cell disease patients

  • by Apoorva Jagadish, Youwei Chen, Hongmei Zhu, Weijia Mai, Shein-Chung Chow, Zhong Li, Grace M. Lee, Marilyn J. Telen, Tim J. McMahon

  • June 29, 2026

Related Content

Coexistence of lymphoplasmacytic lymphoma and multiple myeloma: a case report and review of literature

Case Report: Primary hemophagocytic lymphohistiocytosis with a homozygous PRF1 variant: a case suggesting early immunoporosis and an expanded phenotypic spectrum

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study